BIOS Fund II QP, LP, 10% Owner at Lantern Pharma Inc. (LTRN), sold 40,000 shares at $3.09 ($124K) on 2025-06-13, disclosed to the SEC on 2025-06-13.
Open-market sale of $124k LTRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.09 | 1,903 | $6K | 4.8% |
| 2 | $3.09 | 4,354 | $13K | 10.9% |
| 3 | $3.09 | 7,206 | $22K | 18.0% |
| 4 | $3.09 | 12,319 | $38K | 30.8% |
| 5 | $3.09 | 14,218 | $44K | 35.5% |
| Total | $3.09 avg | 40,000 |
| $124K |
| 100% |
| Filing → |
| INAB | BUY | 2022-08-30 | $165K | — | Filing → |